Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Knight Therapeutics Inc T.GUD

Alternate Symbol(s):  KHTRF

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.


TSX:GUD - Post by User

Comment by MrMugsyon Aug 11, 2021 2:20pm
156 Views
Post# 33685791

RE:RE:RE:RE:RE:RE:RE:RE:2.5 Million Shares Cancelled

RE:RE:RE:RE:RE:RE:RE:RE:2.5 Million Shares CancelledIMO - there is no injured knight.

This is groundhog day - I've been saying it since the first day shares were available.
The path is long and boring.
We move sideways for a very long time.
I know - you consider this backwards ... but it's sideways compared to what I did the first time.

If you're in - you're in on an accumulation basis.
If you're out - you're out until you see the light at the end of the ROW development cycle.
Under any other attempt to get in, you're likely selling your shares and you chalk this one up to your own bad investment.

That's my story since 2014 - since day one of IPO.

Trying to hold me to anything other than that story ... is wrong.
Not understanding why I buy in small morsels it to say you haven't been listening to me.

And no - I'm not from management - I know Goodman's ways ... Groundhog Day it is !  Just a little more complex in what GUD is biting off - they have more cash this time.
<< Previous
Bullboard Posts
Next >>